Torthaí cuardaigh - Abrahamsen, Timothy

  • 1 - 2 toradh as 2 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Design and Rationale of the LAPLACE‐TIMI 57 Trial: A Phase II, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Tolerability of a Monoclonal Antibody Inhibitor of PCSK9 in Subjects With Hypercholesterolemia on Background Statin Therapy

    Design and Rationale of the LAPLACE‐TIMI 57 Trial: A Phase II, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Tolerability of a Monoclonal Antibody Inhibitor of PCSK9 i... de réir Kohli, Payal, Desai, Nihar R., Giugliano, Robert P., Kim, Jae B., Somaratne, Ransi, Huang, Fannie, Knusel, Beat, McDonald, Shannon, Abrahamsen, Timothy, Wasserman, Scott M., Scott, Robert, Sabatine, Marc S.

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study

    Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LA... de réir Giugliano, Robert P, Desai, Nihar R, Kohli, Payal, Rogers, William J, Somaratne, Ransi, Huang, Fannie, Liu, Thomas, Mohanavelu, Satishkumar, Hoffman, Elaine B, McDonald, Shannon T, Abrahamsen, Timothy E, Wasserman, Scott M, Scott, Robert, Sabatine, Marc S

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: